118 related articles for article (PubMed ID: 15034241)
1. Coexistence of primary refractory anemia with ringed sideroblasts and T cell-lymphoblastic non-Hodgkin lymphoma.
Dalamaga M; Karmaniolas K; Chavelas C; Liatis S; Ioannidis P; Matekovits H; Migdalis I
Acta Haematol; 2004; 111(3):171-2. PubMed ID: 15034241
[No Abstract] [Full Text] [Related]
2. Progression of refractory anaemia with ringed sideroblasts (RARS) to B-acute lymphoblastic leukaemia.
Suvajdzic ND; Jankovic GM; Bogdanovic AD; Colovic MD; Rolovic Z
Haematologia (Budap); 1993; 25(4):283-5. PubMed ID: 8157211
[TBL] [Abstract][Full Text] [Related]
3. [Acute lymphoblastic leukemia in refractory anemia with "ringed" sideroblasts].
Suvajdzić N; Janković G; Bogdanović A; Colović M; Rolović Z
Srp Arh Celok Lek; 1992; 120(5-6):193-6. PubMed ID: 1465676
[TBL] [Abstract][Full Text] [Related]
4. [Refractory anemia with ringed sideroblasts complicated with delta beta-thalassemia-like hemoglobinopathy].
Aoyagi Y; Akimoto H; Yamaoka K; Koike A; Kanayama M; Miyaji T; Yamamoto K
Rinsho Ketsueki; 1989 May; 30(5):674-9. PubMed ID: 2477563
[TBL] [Abstract][Full Text] [Related]
5. Refractory anemia with ringed sideroblasts: more than meets the eye.
Gill H; Choi WW; Kwong YL
J Clin Oncol; 2010 Nov; 28(32):e654-5. PubMed ID: 20713854
[No Abstract] [Full Text] [Related]
6. Hook sign and arthritis in refractory anaemia with ringed sideroblasts (myelodysplastic syndrome).
Stride M; Baqai T; Jawad AS
Rheumatology (Oxford); 2009 Mar; 48(3):320-1. PubMed ID: 19151031
[No Abstract] [Full Text] [Related]
7. Refractory anaemia with ringed sideroblasts associated with marked thrombocytosis (RARS-T) with superimposed 5q-syndrome.
Ziarkiewicz M; Dwilewicz-Trojaczek J; Pastwińska A; Chmarzyńska E; Paszkowska-Kowalewska M; Koperski Ł; Jędrzejczak WW; Ziarkiewicz-Wróblewska B
Pol J Pathol; 2010; 61(2):105-9. PubMed ID: 20924996
[TBL] [Abstract][Full Text] [Related]
8. Refractory anemia with ringed sideroblasts and chronic myelomonocytic leukemia: myelodysplastic/myeloproliferative disease.
D'Angelo G
Lab Hematol; 2005; 11(3):171-3. PubMed ID: 16174602
[TBL] [Abstract][Full Text] [Related]
9. The association between the myelodysplastic syndromes and Crohn disease.
Eng C; Farraye FA; Shulman LN; Peppercorn MA; Krauss CM; Connors JM; Stone RM
Ann Intern Med; 1992 Oct; 117(8):661-2. PubMed ID: 1530197
[No Abstract] [Full Text] [Related]
10. [Sideroblastic refractory anemia type myelodysplastic syndrome in a 91-year-old man].
Beauchef A; Siguret V; Yvain F; Andreux MH; Berigaud S; Gaussem P; Andreux JP
Ann Biol Clin (Paris); 1998; 56(3):351-4. PubMed ID: 9754269
[No Abstract] [Full Text] [Related]
11. Refractory anemia with ringed sideroblasts and thrombocytosis without JAK2 V617F mutation: report of three cases.
Tatic A; Vasilică M; Coliţă A; Vasilache D; Dobrea C; Jardan C; Găman AM; Crişan AM; Coliţă D; Coriu D
Rom J Morphol Embryol; 2013; 54(4):1177-82. PubMed ID: 24399021
[TBL] [Abstract][Full Text] [Related]
12. Refractory anaemia with ringed sideroblasts concurrent with multiple myeloma--a brief review of the recent literature.
Shibata K; Shimamoto Y; Nakazato S; Matsuzaki M; Tadano J
Haematologia (Budap); 1997; 28(4):199-205. PubMed ID: 9408763
[TBL] [Abstract][Full Text] [Related]
13. Chronic myelomonocytic leukemia following refractory anemia with sideroblasts: report of two cases.
Bursztyn B; Douer D; Ramot B
Eur J Haematol; 1987 Feb; 38(2):197-9. PubMed ID: 3474153
[TBL] [Abstract][Full Text] [Related]
14. [Clinical, hematologic and developmental characteristics of myelodysplastic syndromes. Study of a group of patients with a long-term follow-up].
Di Giovanni S; Giallonardo P; Costa MP; Carducci P
Recenti Prog Med; 1987 Feb; 78(2):63-8. PubMed ID: 3473582
[No Abstract] [Full Text] [Related]
15. Myelodysplastic syndromes: prognostic significance of multilineage dysplasia in patients with refractory anemia or refractory anemia with ringed sideroblasts.
Dunkley SM; Manoharan A; Kwan YL
Blood; 2002 May; 99(10):3870-1; author reply 3871. PubMed ID: 12014369
[No Abstract] [Full Text] [Related]
16. Ringed sideroblasts with thrombocytosis: an uncommon mixed myelodysplastic/myeloproliferative disease of older adults.
Shaw GR
Br J Haematol; 2005 Oct; 131(2):180-4. PubMed ID: 16197447
[TBL] [Abstract][Full Text] [Related]
17. Occurrence of the JAK2 V617F mutation in the WHO provisional entity: myelodysplastic/myeloproliferative disease, unclassifiable-refractory anemia with ringed sideroblasts associated with marked thrombocytosis.
Remacha AF; Nomdedéu JF; Puget G; Estivill C; Sarda MP; Canals C; Aventin A
Haematologica; 2006 May; 91(5):719-20. PubMed ID: 16670082
[TBL] [Abstract][Full Text] [Related]
18. Vascular events and risk factors for thrombosis in refractory anemia with ring sideroblasts and thrombocytosis.
Patnaik MM; Lasho TL; Finke CM; Hanson CA; King RL; Ketterling RP; Gangat N; Tefferi A
Leukemia; 2016 Nov; 30(11):2273-2275. PubMed ID: 27479179
[No Abstract] [Full Text] [Related]
19. Immature and mature monocyte-derived dendritic cells in myelodysplastic syndromes of subtypes refractory anemia or refractory anemia with ringed sideroblasts display an altered cytokine profile.
Ma L; Ceuppens J; Kasran A; Delforge M; Boogaerts M; Vandenberghe P
Leuk Res; 2007 Oct; 31(10):1373-82. PubMed ID: 17188353
[TBL] [Abstract][Full Text] [Related]
20. Imetelstat therapy in refractory anemia with ring sideroblasts with or without thrombocytosis.
Tefferi A; Al-Kali A; Begna KH; Patnaik MM; Lasho TL; Rizo A; Wan Y; Hanson CA
Blood Cancer J; 2016 Mar; 6(3):e405. PubMed ID: 26967822
[No Abstract] [Full Text] [Related]
[Next] [New Search]
